Delivery Order SPE2DB22D1202-SPE2DB24FUXE2

Award Date 4/16/24
Potential Completion Date 4/17/24
Potential Value $14K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The award, valued at $1,058.60, has a period of performance through March 19, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, with a ceiling value of $14,827.52 and a performance period through April 15, 2024. Amerisourcebergen Drug Corporation is the prime contractor and does not have any major subcontractors listed. This delivery order is placed...
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, with a ceiling value of $3,772.94 and a performance period ending on April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, with a ceiling value of $8,609.00 and a period of performance through April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $8,435.89 and a period of performance through April 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,866.66 contract is for the supply of the prescription medication WEGOVY 1 MG/0.5 ML PEN 0.5ML. The award has an ultimate completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The ceiling value of this firm-fixed-price contract is $3,291.24, with a period of performance through August 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of the prescription medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $2,531.65 and a performance period through March 12, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this award, and does not have any major subcontractors...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The order has a total ceiling value of $14,366.28 and a completion date of February 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a potential value of $7,071.84 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp, as a prime contractor, regularly provides a wide range of pharmaceutical products and medical supplies to the Department of Defense through...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUXE2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the prescription medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $14,432.67 and a completion date of April 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which enables DLA to efficiently procure a wide range of pharmaceutical products and medical supplies for military treatment programs and facilities worldwide. The award is for a firm fixed price delivery order and does not have a set-aside designation.

Generated 7/16/24, 12:31 PM